Patent details

Basic Information

Publication number:

EP3412302

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP181778937

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED FGF-21 POLYPEPTIDES AND USES THEREOF

French Title of Invention:

POLYPEPTIDES FGF-21 MODIFIÉES ET LEURS UTILISATIONS

German Title of Invention:

MODIFIZIERTE FGF-21-POLYPEPTIDE UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

23/10/2015

Grant date:

12/05/2021

EP Publication Date:

12/12/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/05/2021

EP B1 Publication Date:

12/05/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

23/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/05/2021

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

18/05/2021

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

MUKHERJEE, Ranjan

Address:

United States (US)

2

Name:

CHRISTIAN, Rose C.

Address:

United States (US)

3

Name:

COHEN, Daniel

Address:

United States (US)

4

Name:

MORIN, Paul E.

Address:

United States (US)

5

Name:

KRUPINSKI, John

Address:

United States (US)

6

Name:

CAMPHAUSEN, Ray

Address:

United States (US)

7

Name:

LIPOVSEK, Dasa

Address:

United States (US)

8

Name:

REILLY, Timothy P.

Address:

United States (US)

Priority

1

Priority Number:

201462068534 P

Priority Date:

24/10/2014

Priority Country:

United States (US)

2

Priority Number:

201462068514 P

Priority Date:

24/10/2014

Priority Country:

United States (US)

3

Priority Number:

201462068523 P

Priority Date:

24/10/2014

Priority Country:

United States (US)

4

Priority Number:

201462068296 P

Priority Date:

24/10/2014

Priority Country:

United States (US)

5

Priority Number:

201462068526 P

Priority Date:

24/10/2014

Priority Country:

United States (US)

6

Priority Number:

201562141337 P

Priority Date:

01/04/2015

Priority Country:

United States (US)

7

Priority Number:

201562141383 P

Priority Date:

01/04/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; C07K 14/50; A61K 38/18; A61K 45/06; A61K 47/60; A61K 47/64;

Publication

European Patent Bulletin

Issue number:

202119

Publication date:

12/05/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/10/2025

Annual Fee Number:

11

Annual Fee Amount:

148 Euro

Expected Payer:

Last Annual Fee Payment Date:

11/10/2024

Last Annual Fee Paid Number:

10

Last Annual Fee Paid Amount:

131 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
18/05/2021	Outgoing Correspondence	1
18/05/2021	Power Of Attorney	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56